Compare ICUI & CHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICUI | CHH |
|---|---|---|
| Founded | 1984 | 1939 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.4B |
| IPO Year | 1995 | 1997 |
| Metric | ICUI | CHH |
|---|---|---|
| Price | $125.37 | $101.35 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 12 |
| Target Price | ★ $182.25 | $111.45 |
| AVG Volume (30 Days) | 238.1K | ★ 523.7K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.14% |
| EPS Growth | ★ 100.62 | 27.42 |
| EPS | 0.03 | ★ 7.90 |
| Revenue | ★ $2,231,262,000.00 | $1,596,793,000.00 |
| Revenue This Year | N/A | $66.74 |
| Revenue Next Year | $4.46 | $0.49 |
| P/E Ratio | $4,135.83 | ★ $12.76 |
| Revenue Growth | N/A | ★ 0.75 |
| 52 Week Low | $107.02 | $84.04 |
| 52 Week High | $160.29 | $136.45 |
| Indicator | ICUI | CHH |
|---|---|---|
| Relative Strength Index (RSI) | 37.07 | 50.64 |
| Support Level | $122.17 | $99.40 |
| Resistance Level | $125.00 | $103.62 |
| Average True Range (ATR) | 4.84 | 2.88 |
| MACD | 0.15 | 0.54 |
| Stochastic Oscillator | 15.61 | 88.49 |
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.
At year-end 2025, Choice Hotels operated 657,000 rooms across the economy, midscale, upscale, and extended-stay segments. Comfort Inn and Comfort Suites are the largest brands (27% of the company's total rooms), while Ascend and Cambria (10%) are lifestyle and select-service brands, and WoodSpring (5%) is the company's largest extended-stay brand. Choice closed on its Radisson acquisition in August 2022, which added about 70,000 rooms. Franchises account for 100% of total revenue, and the United States represented 78% of total rooms in 2024.